CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase II Trial of ACT001 in Children and Adolescents With Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06838676
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:08.033318+00:00
- Published At
- 2026-03-27T00:00:00+00:00
- Record Updated At
- 2026-03-27
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Diffuse Intrinsic Pontine Gliomas (DIPG)", "Progressive DIPG", "Refractory DIPG", "Recurrent DIPG", "H3K27-altered High Grade Glioma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-27"- protocolSection.identificationModule.nctId
"NCT06838676"- protocolSection.identificationModule.officialTitle
"A Phase II Trial of ACT001 in Children and Adolescents With Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.